Literature DB >> 8268649

Deficiency of serum ionized magnesium in patients receiving hemodialysis or peritoneal dialysis.

M S Markell1, B T Altura, Y Sarn, B G Delano, O Ifudu, E A Friedman, B M Altura.   

Abstract

Serum total magnesium (TMg) measurements in dialysis patients are variable, with some groups reporting hypermagnesemia and some hypomagnesemia. It had not been possible to measure the biologically active fraction, ionized magnesium (IMg2+). The authors utilized an ion-selective electrode to measure IMg in 26 hemodialysis patients and 10 peritoneal dialysis (CAPD) patients and compared the results with those from 66 age matched control subjects. Dialysate magnesium was 0.375 mM/L for the hemodialysis and 0.25 mM/L for the CAPD patients. When compared with control subjects, both hemodialysis and CAPD patients had significantly lower IMg2+ (0.55 +/- 0.02 and 0.50 +/- 0.02 vs. 0.60 +/- 0.004 mM/L; p < 0.05) and greater or normal TMg values (0.99 +/- 0.04, different at the p < 0.001 level, and 0.85 +/- 0.04 vs. 0.84 +/- 0.008). Ionized calcium (ICa2+) values were similar for all three groups (1.15 +/- 0.02 and 1.21 +/- 0.04 vs. 1.17 +/- 0.01), resulting in increased mean ICa2+/IMg2+ ratios (2.14 +/- 0.07 and 2.42 +/- 0.06 vs. 1.95 +/- 0.02 for the control subjects; p < 0.05). The percent of total magnesium that was ionized (%IMg2+) was low in both the hemodialysis and CAPD patients (55.6 +/- 0.93 and 59.2 +/- 1.05) compared with that of control subjects (72 +/- 0.61; p < 0.05). IMg2+ values correlated with TMg values in both hemodialysis (r = 0.93; p < 0.0001) and CAPD (r = 0.92; p < 0.0001) patients did not correlate with age, time on dialysis, weight, fasting cholesterol or triglyceride, albumin, blood urea nitrogen (BUN), creatinine, hematocrit, phosphate, or PTH values.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8268649

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  6 in total

1.  Short-term magnesium deficiency downregulates telomerase, upregulates neutral sphingomyelinase and induces oxidative DNA damage in cardiovascular tissues: relevance to atherogenesis, cardiovascular diseases and aging.

Authors:  Nilank C Shah; Gatha J Shah; Zhiqiang Li; Xian-Cheng Jiang; Bella T Altura; Burton M Altura
Journal:  Int J Clin Exp Med       Date:  2014-03-15

2.  Hypomagnesemia and Mortality in Incident Hemodialysis Patients.

Authors:  Lin Li; Elani Streja; Connie M Rhee; Rajnish Mehrotra; Melissa Soohoo; Steven M Brunelli; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2015-07-14       Impact factor: 8.860

3.  Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients.

Authors:  John Cunningham; Mariano Rodríguez; Piergiorgio Messa
Journal:  Clin Kidney J       Date:  2012-02

Review 4.  Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis.

Authors:  James J DiNicolantonio; James H O'Keefe; William Wilson
Journal:  Open Heart       Date:  2018-01-13

5.  Reduced Mortality in Maintenance Haemodialysis Patients on High versus Low Dialysate Magnesium: A Pilot Study.

Authors:  Christoph Schmaderer; Matthias C Braunisch; Yana Suttmann; Georg Lorenz; Dang Pham; Bernhard Haller; Susanne Angermann; Julia Matschkal; Lutz Renders; Marcus Baumann; Jürgen R Braun; Uwe Heemann; Claudius Küchle
Journal:  Nutrients       Date:  2017-08-23       Impact factor: 5.717

6.  Routine hemodialysis induces a decline in plasma magnesium concentration in most patients: a prospective observational cohort study.

Authors:  Nicoline H J Leenders; Frans J van Ittersum; Tiny Hoekstra; Joost G J Hoenderop; Marc G Vervloet
Journal:  Sci Rep       Date:  2018-07-06       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.